Medicine and Dentistry
Optical Coherence Tomography
100%
Visual Acuity
96%
Age Related Macular Degeneration
89%
Diabetic Macular Edema
65%
Vasculotropin
63%
Macular Edema
54%
Diabetic Retinopathy
52%
Wet Macular Degeneration
47%
Geographic Atrophy
40%
Retina Vein Occlusion
37%
Choroidal Neovascularization
36%
Multiple Sclerosis
34%
Eye Disease
30%
Retinal Detachment
24%
Photodynamic Therapy
24%
Bleeding
24%
Edema
24%
Fluorescein Angiography
22%
Retinal Vein Occlusion
22%
Best Corrected Visual Acuity
21%
Visual Impairment
19%
Laser Coagulation
19%
Fluorescein
19%
Prevalence
18%
Verteporfin
16%
Disease
15%
Endothelial Cell Growth Factor
15%
Observational Study
14%
Odds Ratio
13%
Proliferative Diabetic Retinopathy
13%
Randomized Clinical Trial
13%
Central Scotoma
12%
Voxel-Based Morphometry
12%
Retina Neovascularization
12%
Atezolizumab
12%
Laser-Induced Choroidal Neovascularization
12%
Retinopathy
12%
Vein Occlusion
12%
Patient Preference
12%
Nd:YAG Laser
12%
Cataract Surgery
12%
Ultrasound Biomicroscopy
12%
Cancer Immunotherapy
12%
Dilated Fundus Examination
12%
Retreatment
12%
Endothelial Cell
12%
Exudative Retinal Detachment
12%
Eye Care
12%
Cancer
12%
Contact Lens
12%
Keyphrases
Optical Coherence Tomography
79%
Diabetic Macular Edema
65%
Visual Acuity
65%
Age-related Macular Degeneration
55%
Ranibizumab
53%
Best-corrected Visual Acuity
48%
Vascular Endothelial Growth Factor
43%
Neovascular Age-related Macular Degeneration (nAMD)
42%
Anti-vascular Endothelial Growth Factor Therapy
42%
Retinal Vein Occlusion
37%
Macular Edema
37%
Central Subfield Thickness
35%
Bevacizumab
34%
Retina
31%
Proliferative Diabetic Retinopathy
28%
Edema
26%
Macular
26%
Geographic Atrophy
26%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
26%
Eye Care
24%
Confidence Interval
22%
Vision Loss
22%
Good Visual Acuity
19%
Prospective Randomized Trial
18%
Perifovea
17%
Disease Course
16%
Advanced Age-related Macular Degeneration
16%
Boundary Evolution
16%
Scotoma
16%
Parafovea
15%
Visual Loss
15%
Myopic Choroidal Neovascularization (mCNV)
14%
Treatment Burden
14%
Clinic Visits
14%
Spectral Domain Optical Coherence Tomography (SD-OCT)
14%
Hemoglobin A1c (HbA1c)
14%
Angiogenic Factors
13%
Retinal Neovascularization
13%
Growth Factor Concentration
13%
Thickness Change
13%
Healthy Controls
13%
Retreatment
13%
Foveal Thickness
12%
Aflibercept
12%
Anti-VEGF Therapy
12%
Submacular Surgery
12%
Plasma Vascular Endothelial Growth Factor
12%
Voxel-based Morphometry
12%
Protocol T
12%
SDH1
12%